Royalty Pharma Plc (RPRX)
54.97
+0.96
(+1.78%)
USD |
NASDAQ |
Jun 03, 16:00
55.35
+0.38
(+0.69%)
Pre-Market: 08:14
Royalty Pharma Profit Margin (Quarterly) : 74.26% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 21.75% |
| Zymeworks, Inc. | -1.83K% |
| ANI Pharmaceuticals, Inc. | 11.55% |
| Corcept Therapeutics, Inc. | -18.92% |
| Elanco Animal Health, Inc. | 4.16% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.99% |
| Return on Assets | 7.17% |
| Return on Invested Capital | 7.46% |
| Gross Profit Margin (Quarterly) | 99.81% |
| Return on Net Operating Assets | 7.85% |